{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T03:01:29Z","timestamp":1789441289372,"version":"build-2803163510"},"reference-count":37,"publisher":"Wiley","issue":"12","license":[{"start":{"date-parts":[[2005,12,12]],"date-time":"2005-12-12T00:00:00Z","timestamp":1134345600000},"content-version":"vor","delay-in-days":2933,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arthritis &amp; Rheumatism"],"published-print":{"date-parts":[[1997,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:italic>Objective<\/jats:italic>. To investigate the effectiveness and side effects of oral versus pulse cyclophosphamide (CYC) in combination with corticosteroids (CS) in the treatment of systemic Wegener's granulomatosis (WG).<\/jats:p><jats:p><jats:italic>Methods<\/jats:italic>. Patients with newly diagnosed systemic WG were enrolled in a prospective, randomized trial. At the time of diagnosis, prior to randomization, every patient received a daily injection of methylprednisolone for 3 days, followed by daily oral prednisone (1 mg\/kg\/day) and a 0.7\u2010gm\/m<jats:sup>2<\/jats:sup> pulse of CYC. Patients were then randomly assigned to receive either prednisone plus intravenous pulse CYC (group A) or prednisone plus oral CYC (group B) as first\u2010line treatment. CYC was given for at least 1 year and was then progressively tapered and discontinued.<\/jats:p><jats:p><jats:italic>Results<\/jats:italic>. Fifty patients were included in the study: 27 in group A and 23 in group B. At 6 months, 24 group A patients (88.9%) were in remission, versus 18 group B patients (78.3%). At the end of the trial, 18 group A patients (66.7%) and 13 group B patients (56.5%) were in remission. In group A, 66.7% of the patients experienced side effects, versus 69.6% in group B. Infectious side effects were significantly more frequent in group B (69.6%) than in group A (40.7%) (<jats:italic>P<\/jats:italic> &lt; 0.05). The incidence of <jats:italic>Pneumocystis carinii<\/jats:italic> pneumonia was higher in oral CYC\u2010treated patients (30.4%) than in pulse CYC\u2010treated patients (11.1%). Nine group A patients (33.3%) and 10 group B patients (43.5%) died. Actuarial curves showed that relapses were significantly more frequent in group A (59.2%) than in group B (13%) (<jats:italic>P<\/jats:italic> = 0.02).<\/jats:p><jats:p><jats:italic>Conclusion<\/jats:italic>. Our results indicate that pulse CYC is as effective as oral CYC in achieving initial remission of WG and is associated with fewer side effects and lower mortality. However, in the long term, treatment with pulse CYC does not maintain remission or prevent relapses as well as oral CYC.<\/jats:p>","DOI":"10.1002\/art.1780401213","type":"journal-article","created":{"date-parts":[[2007,2,14]],"date-time":"2007-02-14T12:10:55Z","timestamp":1171455055000},"page":"2187-2198","source":"Crossref","is-referenced-by-count":400,"title":["A prospective, multicenter, randomized trial comparing steroids and pulse cyclophosphamide versus steroids and oral cyclophosphamide in the treatment of generalized wegener's granulomatosis"],"prefix":"10.1002","volume":"40","author":[{"given":"Lo\u00efc","family":"Guillevin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean\u2010Fran\u00e7ois","family":"Cordier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00efois","family":"Lhote","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Jarrousse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Royer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Lesavre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Jacquot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Bindi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Bielefeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean\u2010Fran\u00efois","family":"Desson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9rick","family":"D\u00e9tr\u00e9e","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Dubois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Hachulla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Hoen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Jacomy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Seigneuric","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Lauque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Stern","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mait\u00e9","family":"Longy\u2010Boursier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2005,12,12]]},"reference":[{"key":"e_1_2_1_2_2","first-page":"202","article-title":"\u00dcber generalisierte septische Gef\u00e4sserkrankungen","volume":"29","author":"Wegener F","year":"1936","journal-title":"Verh Dtsch Ges Pathol"},{"key":"e_1_2_1_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(85)91147-X"},{"key":"e_1_2_1_4_2","first-page":"11","article-title":"Immunodiagnostic pathophysiologic aspects of antineutrophil cytoplasmic antibodies in vasculitis","volume":"7","author":"Gross WL","year":"1995","journal-title":"Curr Opin Rheumatol"},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-98-1-76"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-116-6-488"},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.1002\/anr.1780320108"},{"key":"e_1_2_1_8_2","first-page":"1","article-title":"Infection and immunosuppression","volume":"51","author":"Cohen J","year":"1982","journal-title":"Q J Med"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197908023010503"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780310918"},{"key":"e_1_2_1_11_2","first-page":"416","article-title":"Traitement des maladies syst\u00e9miques par bolus de cyclophosphamide: 15 observations","volume":"141","author":"Amoura Z","year":"1990","journal-title":"Ann Med Interne (Paris)"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2796.1992.tb00584.x"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.1136\/ard.51.7.885"},{"key":"e_1_2_1_14_2","first-page":"550","article-title":"Treatment of polyarteritis nodosa and microscopic polyangiitis","volume":"145","author":"Lhote F","year":"1994","journal-title":"Ann Med Interne (Paris)"},{"key":"e_1_2_1_15_2","first-page":"566","article-title":"Treatment of vasculitis in rheumatoid arthritis","volume":"145","author":"Luqmani R","year":"1994","journal-title":"Ann Med Interne (Paris)"},{"key":"e_1_2_1_16_2","first-page":"179","article-title":"Cyclophosphamide pulses in the treatment of rheumatic diseases: an update","volume":"9","author":"De Vita S","year":"1991","journal-title":"Clin Exp Rheumatol"},{"key":"e_1_2_1_17_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0463.1990.tb05746.x"},{"key":"e_1_2_1_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(90)90367-M"},{"key":"e_1_2_1_19_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-124-5-199603010-00003"},{"key":"e_1_2_1_20_2","first-page":"405","article-title":"Treatment of polyarteritis nodosa and Churg\u2010Strauss syndrome: a meta\u2010analysis of 3 prospective controlled trials including 182 patients over 12 years","volume":"143","author":"Guillevin L","year":"1992","journal-title":"Ann Med Interne (Paris)"},{"key":"e_1_2_1_21_2","doi-asserted-by":"publisher","DOI":"10.1080\/01621459.1958.10501452"},{"key":"e_1_2_1_22_2","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1977.1"},{"key":"e_1_2_1_23_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780330807"},{"key":"e_1_2_1_24_2","first-page":"169","article-title":"La granulomatose de Wegener: aspects cliniques et probl\u00e8mes nosologiques; revue de la litt\u00e9rature \u00e0 propos de 30 cas","volume":"139","author":"Le Thi Huong D","year":"1988","journal-title":"Ann Med Interne (Paris)"},{"key":"e_1_2_1_25_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4757-9182-2_89"},{"key":"e_1_2_1_26_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002281-199401000-00003"},{"key":"e_1_2_1_27_2","first-page":"263","article-title":"Immunosuppressive therapy for autoimmune diseases","volume":"70","author":"Hoffman GS","year":"1993","journal-title":"Ann Allergy"},{"key":"e_1_2_1_28_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780370622"},{"key":"e_1_2_1_29_2","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/33.10.959"},{"key":"e_1_2_1_30_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-113-9-656"},{"key":"e_1_2_1_31_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/6.8.531"},{"key":"e_1_2_1_32_2","first-page":"615","article-title":"Increased risk of Pneumocystis carinii pneumonia in patients with Wegener's granulomatosis","volume":"11","author":"Jarrousse B","year":"1993","journal-title":"Clin Exp Rheumatol"},{"key":"e_1_2_1_33_2","first-page":"246","article-title":"Pneumocystis carinii pneumonia in the course of connective tissue disease: report of 34 cases","volume":"21","author":"Godeau B","year":"1994","journal-title":"J Rheumatol"},{"key":"e_1_2_1_34_2","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.151.3.7881673"},{"key":"e_1_2_1_35_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199607043350103"},{"key":"e_1_2_1_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(96)80066-0"},{"key":"e_1_2_1_37_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780351113"},{"key":"e_1_2_1_38_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780380505"}],"container-title":["Arthritis &amp; Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fart.1780401213","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/art.1780401213","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,23]],"date-time":"2023-11-23T17:02:01Z","timestamp":1700758921000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/art.1780401213"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,12]]},"references-count":37,"journal-issue":{"issue":"12","published-print":{"date-parts":[[1997,12]]}},"alternative-id":["10.1002\/art.1780401213"],"URL":"https:\/\/doi.org\/10.1002\/art.1780401213","archive":["Portico"],"relation":{},"ISSN":["0004-3591","1529-0131"],"issn-type":[{"value":"0004-3591","type":"print"},{"value":"1529-0131","type":"electronic"}],"subject":[],"published":{"date-parts":[[1997,12]]}}}